Physicochemical Properties
| Molecular Formula | C36H43N13O4 |
| Molecular Weight | 721.81 |
| Exact Mass | 721.356 |
| CAS # | 2137975-93-8 |
| PubChem CID | 131997716 |
| Appearance | White to light yellow solid powder |
| LogP | 1.5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 15 |
| Heavy Atom Count | 53 |
| Complexity | 1290 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | N1N(CC)C(=CC=1C)C(NC1=NC2=C(C=CC(C(=O)N)=C2)N1CCCCN1C(NC(C2=CC(C)=NN2CC)=O)=NC2=C1C=CC(C(NCCN)=O)=C2)=O |
| InChi Key | OFHOFLFXGGZWEH-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C36H43N13O4/c1-5-48-29(17-21(3)44-48)33(52)42-35-40-25-19-23(31(38)50)9-11-27(25)46(35)15-7-8-16-47-28-12-10-24(32(51)39-14-13-37)20-26(28)41-36(47)43-34(53)30-18-22(4)45-49(30)6-2/h9-12,17-20H,5-8,13-16,37H2,1-4H3,(H2,38,50)(H,39,51)(H,40,42,52)(H,41,43,53) |
| Chemical Name | 1-[4-[5-(2-aminoethylcarbamoyl)-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]butyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazole-5-carboxamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The scientists created linked aminobenzimidazole (ABZI) compounds, or diABZIs, by ligation approach to combine the effects of two symmetry-based ABZI compounds and improve binding to STING and cellular function. Immunocompetent animals with established syngeneic colon cancers showed robust anticancer action and full and long-lasting tumor remission when intravenous diABZI STING agonist was administered [1]. Potential target proteins from THP1 cell lysates were selectively captured using diABZI-C2-NH2, which was covalently bound on agarose beads [1]. |
| References |
[1]. Design of amidobenzimidazole STING receptor agonists with systemic activity [published correction appears in Nature. 2019 Jun;570(7761):E53]. Nature. 2018;564(7736):439-443. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (138.54 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (3.46 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (3.46 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.3854 mL | 6.9270 mL | 13.8541 mL | |
| 5 mM | 0.2771 mL | 1.3854 mL | 2.7708 mL | |
| 10 mM | 0.1385 mL | 0.6927 mL | 1.3854 mL |